EBS Latest Press Releases

-- November 4, 2026 --

Emergent BioSolutions Receives $22.3 Million Delivery Order Modification to Supply BioThrax (Anthrax Vaccine Adsorbed) to the U.S. Department of War Business Wire 4:05 PM

-- November 2, 2026 --

Emergent Biosolutions Reports Third Quarter 2026 Financial Results Business Wire 4:05 PM

-- October 16, 2026 --

Emergent BioSolutions Announces Retirement of Chief Financial Officer Richard S. Lindahl Business Wire 7:50 AM

-- October 15, 2026 --

Emergent BioSolutions to Report Third Quarter 2026 Financial Results on November 2, 2026 Business Wire 8:00 AM

-- September 24, 2026 --

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Emergent BioSolutions Inc. - EBS PRNewswire 6:39 PM

-- September 22, 2026 --

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Emergent BioSolutions Inc. - EBS Globe Newswire 8:46 PM

-- September 15, 2026 --

Media Advisory: Emergent to Host Ribbon Cutting Ceremony at Canton Manufacturing Facility Globe Newswire 7:45 AM

-- September 8, 2026 --

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Emergent BioSolutions Inc. - EBS Globe Newswire 5:56 PM

-- September 3, 2026 --

Emergent BioSolutions Completes Repurchase of $75 Million Aggregate Principal Amount of Senior Unsecured Notes Globe Newswire 7:45 AM

-- September 1, 2026 --

Emergent BioSolutions Awarded Contract Modification Valued at Approximately $24 Million for CYFENDUS (Anthrax Vaccine Adsorbed, Adjuvanted) Globe Newswire 7:55 AM

-- August 31, 2026 --

Emergent BioSolutions Awarded Government of Canada Standing Offer for NARCAN Nasal Spray Globe Newswire 7:55 AM

Emergent BioSolutions Reinforces Commitment to Opioid Overdose Education and Preparedness on International Overdose Awareness Day Globe Newswire 7:54 AM

-- August 27, 2026 --

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Emergent BioSolutions Inc. - EBS PRNewswire 4:30 PM

-- August 25, 2026 --

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Emergent BioSolutions Inc. - EBS Globe Newswire 6:35 PM

-- August 19, 2026 --

Emergent BioSolutions Inc. (EBS) Shareholders Who Lost Money - Contact Law Offices of Howard G. Smith About Securities Fraud Investigation Business Wire 9:00 AM

-- August 18, 2026 --

Securities Fraud Investigation Into Emergent BioSolutions Inc. (EBS) Announced - Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz Business Wire 12:40 PM

-- August 17, 2026 --

EBS Investors Have Opportunity to Join Emergent BioSolutions Inc. Fraud Investigation with SBS Law Business Wire 1:38 PM

Emergent BioSolutions (EBS) Securities Investigation Notice - Levi & Korsinsky PRNewswire 10:09 AM

-- August 13, 2026 --

Levi & Korsinsky Notifies Investors of Pending Investigation Into Securities Claims Involving Emergent BioSolutions (EBS) Globe Newswire 10:11 AM

-- August 12, 2026 --

EBS Investor Alert: Levi & Korsinsky Notifies Investors of Investigation Into Emergent BioSolutions (EBS) Business Wire 10:17 AM

-- August 11, 2026 --

EBS SHAREHOLDER INVESTIGATION: SueWallSt Notifies Investors of Potential Securities Claims Involving Emergent BioSolutions PRNewswire 10:07 AM

-- August 10, 2026 --

Emergent BioSolutions Investigation Notice: Levi & Korsinsky Notifies Investors of Pending Investigation Into Emergent BioSolutions (EBS) PRNewswire 6:19 PM

-- August 5, 2026 --

Emergent BioSolutions Commits to Cross-Sector Collaboration Against Biological Threats in an Evolving Global Security Environment Globe Newswire 4:07 PM

Emergent BioSolutions Reports Second Quarter 2026 Financial Results Globe Newswire 4:07 PM

-- July 22, 2026 --

Emergent BioSolutions to Report Second Quarter 2026 Financial Results on August 5, 2026 Globe Newswire 4:01 PM

-- June 29, 2026 --

Emergent BioSolutions Secures Contract Modification Valued at Approximately $52.7 Million for ACAM2000 (Smallpox and Mpox (Vaccinia) Vaccine, Live) from the U.S. Government Globe Newswire 9:13 AM